{"regulatoryDesignationsTreeTaxonomyOutput":{"serviceExecutionTime":0,"TaxonomyTree":{"Node":[{"@name":"Orphan Drug","@id":"1"},{"@name":"Fast Track","@id":"2"},{"@name":"Breakthrough Therapy","@id":"3"},{"@name":"Advanced Therapy Medicinal Product","@id":"4"},{"@name":"Accelerated Approval","@id":"5"},{"@name":"Animal Rule","@id":"6"},{"@name":"Emergency Use Authorization","@id":"7"},{"@name":"National Science and Technology Major Project","@id":"18"},{"@name":"New Active Substance","@id":"8"},{"@name":"Paediatric Investigation Plan","@id":"9"},{"@name":"PRIME","@id":"10"},{"@name":"Priority Review","@id":"11"},{"@name":"Promising Innovative Medicine","@id":"16"},{"@name":"Qualified Infectious Disease Product","@id":"12"},{"@name":"Rare Pediatric Disease","@id":"13"},{"@name":"Regenerative Medicine Advanced Therapy","@id":"17"},{"@name":"Sakigake","@id":"14"},{"@name":"Special Review Project","@id":"19"},{"@name":"Tropical Disease Priority Review","@id":"15"}]}}}